Symbols / YI $6.75 -1.75% 111, Inc.

Healthcare • Medical Distribution • China • NGM
YI Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides pharmaceutical products and other merchandise. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Fundamentals
Scroll to Statements
Market Cap 58.51M Enterprise Value 1.78B Income -66.39M Sales 12.56B Book/sh -11.39 Cash/sh 3.20
Dividend Yield Payout 0.00% Employees IPO P/E Forward P/E 48.21
PEG P/S 0.00 P/B -0.59 P/C EV/EBITDA 121.81 EV/Sales 0.14
Quick Ratio 0.45 Current Ratio 1.09 Debt/Eq 101.48 LT Debt/Eq EPS (ttm) -22.29 EPS next Y 0.14
EPS Growth Revenue Growth -26.70% Earnings 2026-03-19 ROA -0.06% ROE -7.57% ROIC
Gross Margin 3.01% Oper. Margin -0.01% Profit Margin -0.53% Shs Outstand 5.07M Shs Float 87.15M Short Float 0.58%
Short Ratio 1.94 Short Interest 52W High 11.17 52W Low 2.48 Beta 0.70 Avg Volume 29.26K
Volume 6.68K Target Price Recom None Prev Close $6.87 Price $6.75 Change -1.75%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
$6.75
Latest analyst target
3. DCF / Fair value
$1058.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.75
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
14,401.25
-3.66%
14,948.13
+10.59%
13,516.70
+8.78%
12,425.90
Operating Revenue
14,401.25
-3.66%
14,948.13
+10.59%
13,516.70
+8.78%
12,425.90
Cost Of Revenue
13,572.02
-3.74%
14,099.15
+11.22%
12,676.72
+7.39%
11,804.81
Reconciled Cost Of Revenue
13,572.02
-3.74%
14,099.15
+11.22%
12,676.72
+7.39%
11,804.81
Gross Profit
829.23
-2.33%
848.98
+1.07%
839.98
+35.24%
621.10
Operating Expense
827.12
-31.02%
1,199.08
-0.98%
1,210.98
-4.14%
1,263.23
Selling General And Administration
384.80
-42.79%
672.59
+1.37%
663.50
-7.86%
720.13
Selling And Marketing Expense
313.90
-29.99%
448.39
-2.07%
457.88
-10.77%
513.15
General And Administrative Expense
70.91
-68.37%
224.20
+9.04%
205.62
-0.66%
206.98
Other Gand A
70.91
-68.37%
224.20
+9.04%
205.62
-0.66%
206.98
Other Operating Expenses
442.31
-15.99%
526.49
-3.83%
547.47
+0.80%
543.11
Total Expenses
14,399.14
-5.88%
15,298.23
+10.16%
13,887.70
+6.27%
13,068.04
Operating Income
2.11
+100.60%
-350.10
+5.63%
-371.00
+42.22%
-642.14
Total Operating Income As Reported
2.11
+100.60%
-350.10
+5.63%
-371.00
+42.22%
-642.14
EBITDA
24.62
+107.91%
-311.26
+3.28%
-321.81
+45.30%
-588.32
Normalized EBITDA
25.53
+108.19%
-311.87
+0.66%
-313.93
+46.81%
-590.25
Reconciled Depreciation
16.97
-22.10%
21.78
-46.64%
40.82
+49.95%
27.22
EBIT
7.65
+102.30%
-333.04
+8.16%
-362.63
+41.09%
-615.54
Total Unusual Items
-0.91
-249.02%
0.61
+107.75%
-7.88
-506.56%
1.94
Total Unusual Items Excluding Goodwill
-0.91
-249.02%
0.61
+107.75%
-7.88
-506.56%
1.94
Net Income
-64.74
+83.51%
-392.69
+5.80%
-416.88
+37.76%
-669.81
Pretax Income
-20.68
+94.14%
-353.18
+6.09%
-376.07
+39.44%
-621.02
Net Non Operating Interest Income Expense
-21.29
-88.29%
-11.31
-112.34%
-5.33
-224.18%
4.29
Interest Expense Non Operating
28.33
+40.66%
20.14
+49.83%
13.44
+144.95%
5.49
Net Interest Income
-21.29
-88.29%
-11.31
-112.34%
-5.33
-224.18%
4.29
Interest Expense
28.33
+40.66%
20.14
+49.83%
13.44
+144.95%
5.49
Interest Income Non Operating
7.04
-20.30%
8.83
+8.82%
8.12
-16.96%
9.78
Interest Income
7.04
-20.30%
8.83
+8.82%
8.12
-16.96%
9.78
Other Income Expense
-1.50
-118.29%
8.22
+3099.22%
0.26
-98.47%
16.83
Other Non Operating Income Expenses
-0.59
-107.82%
7.61
-6.39%
8.13
-45.39%
14.89
Gain On Sale Of Security
-0.91
-249.02%
0.61
+107.75%
-7.88
-506.56%
1.94
Tax Provision
0.10
-61.75%
0.25
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.23
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-20.78
+94.12%
-353.43
+6.02%
-376.07
+39.44%
-621.02
Net Income From Continuing Operation Net Minority Interest
-64.74
+83.51%
-392.69
+5.80%
-416.88
+37.76%
-669.81
Net Income From Continuing And Discontinued Operation
-64.74
+83.51%
-392.69
+5.80%
-416.88
+37.76%
-669.81
Net Income Continuous Operations
-20.78
+94.12%
-353.43
+6.02%
-376.07
+39.44%
-621.02
Minority Interests
-43.97
-11.99%
-39.26
+3.80%
-40.81
+16.35%
-48.78
Normalized Income
-64.06
+83.71%
-393.30
+3.84%
-409.00
+39.11%
-671.75
Net Income Common Stockholders
-64.74
+83.51%
-392.69
+5.80%
-416.88
+37.76%
-669.81
Diluted EPS
-7.60
+83.69%
-46.60
+6.80%
-50.00
+38.12%
-80.80
Basic EPS
-7.60
+83.69%
-46.60
+6.80%
-50.00
+38.12%
-80.80
Basic Average Shares
8.59
+1.91%
8.43
+1.19%
8.33
+0.46%
8.29
Diluted Average Shares
8.59
+1.91%
8.43
+1.19%
8.33
+0.46%
8.29
Diluted NI Availto Com Stockholders
-64.74
+83.51%
-392.69
+5.80%
-416.88
+37.76%
-669.81
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
2,787.75
-9.75%
3,089.04
-11.08%
3,473.81
+10.43%
3,145.83
Current Assets
2,649.66
-9.67%
2,933.33
-9.35%
3,235.82
+15.49%
2,801.74
Cash Cash Equivalents And Short Term Investments
462.29
-29.28%
653.67
-25.68%
879.53
+4.22%
843.95
Cash And Cash Equivalents
462.29
-23.40%
603.52
-10.41%
673.67
+1.86%
661.39
Other Short Term Investments
0.00
-100.00%
50.14
-75.64%
205.86
+12.77%
182.56
Receivables
630.72
-18.78%
776.51
+7.79%
720.36
+8.33%
665.00
Accounts Receivable
413.10
-23.05%
536.82
+9.81%
488.88
+20.87%
404.47
Gross Accounts Receivable
416.32
-23.06%
541.11
+9.87%
492.50
+21.42%
405.62
Allowance For Doubtful Accounts Receivable
-3.22
+24.73%
-4.28
-17.96%
-3.63
-216.20%
-1.15
Other Receivables
82.96
-23.05%
107.81
-21.03%
136.52
+75.73%
77.69
Taxes Receivable
55.84
+2.86%
54.28
+5.13%
51.63
-43.94%
92.11
Inventory
1,387.40
-2.25%
1,419.40
-5.30%
1,498.90
+33.70%
1,121.11
Finished Goods
1,387.40
-2.25%
1,419.40
-5.30%
1,498.90
+33.70%
1,121.11
Prepaid Assets
106.43
+95.90%
54.33
-37.12%
86.40
+30.03%
66.44
Restricted Cash
56.04
+179.87%
20.02
-53.56%
43.12
-56.57%
99.28
Other Current Assets
6.78
-27.95%
9.40
+25.22%
7.51
+25.99%
5.96
Total Non Current Assets
138.09
-11.31%
155.71
-34.57%
237.99
-30.84%
344.10
Net PPE
121.97
-11.70%
138.14
-34.95%
212.37
-32.39%
314.10
Gross PPE
201.17
-26.52%
273.78
-16.98%
329.77
-17.21%
398.33
Accumulated Depreciation
-79.20
+41.61%
-135.64
-15.54%
-117.40
-39.37%
-84.23
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
89.07
-14.19%
103.80
-36.66%
163.88
Machinery Furniture Equipment
36.57
Construction In Progress
0.00
Other Properties
201.17
-26.52%
273.78
+65.03%
165.90
-58.35%
398.33
Leases
91.91
Goodwill And Other Intangible Assets
1.44
-36.30%
2.26
-30.95%
3.27
-33.45%
4.91
Investments And Advances
0.00
-100.00%
2.00
+0.00%
2.00
-33.33%
3.00
Other Non Current Assets
14.68
+10.31%
13.31
-34.59%
20.35
-7.87%
22.09
Total Liabilities Net Minority Interest
2,406.99
-14.43%
2,812.93
-0.45%
2,825.58
+23.00%
2,297.13
Current Liabilities
2,342.58
-14.66%
2,745.06
+0.73%
2,725.11
+27.94%
2,129.98
Payables And Accrued Expenses
1,864.89
-6.41%
1,992.56
+1.28%
1,967.28
+28.35%
1,532.73
Payables
1,807.05
-5.61%
1,914.41
+1.44%
1,887.28
+27.39%
1,481.54
Accounts Payable
1,721.42
+8.35%
1,588.69
-9.98%
1,764.85
+30.99%
1,347.35
Other Payable
81.40
-74.46%
318.77
+276.39%
84.69
-31.28%
123.25
Current Accrued Expenses
57.84
-25.99%
78.14
-2.32%
80.00
+56.28%
51.19
Total Tax Payable
4.22
-39.19%
6.95
-81.59%
37.73
+245.07%
10.94
Current Debt And Capital Lease Obligation
201.32
-47.10%
380.61
+56.16%
243.72
-25.10%
325.40
Current Debt
160.98
-52.38%
338.07
+88.88%
178.99
-31.07%
259.66
Current Capital Lease Obligation
40.34
-5.15%
42.53
-34.30%
64.73
-1.53%
65.74
Current Deferred Liabilities
185.87
+21.09%
153.50
-52.56%
323.57
+59.74%
202.56
Current Deferred Revenue
185.87
+21.09%
153.50
-52.56%
323.57
+59.74%
202.56
Other Current Liabilities
90.50
-58.56%
218.40
+14.63%
190.54
+174.99%
69.29
Total Non Current Liabilities Net Minority Interest
64.41
-5.10%
67.87
-32.45%
100.47
-39.89%
167.15
Long Term Debt And Capital Lease Obligation
55.45
-11.46%
62.62
-37.67%
100.47
-39.34%
165.61
Long Term Capital Lease Obligation
55.45
-11.46%
62.62
-37.67%
100.47
-39.34%
165.61
Other Non Current Liabilities
8.96
+70.85%
5.25
1.54
Stockholders Equity
-642.64
-10.15%
-583.45
-40.73%
-414.60
-139.21%
-173.32
Common Stock Equity
-642.64
-10.15%
-583.45
-40.73%
-414.60
-139.21%
-173.32
Capital Stock
0.06
+1.75%
0.06
+1.79%
0.06
+0.00%
0.06
Common Stock
0.06
+1.75%
0.06
+1.79%
0.06
+0.00%
0.06
Share Issued
173.21
+1.07%
171.38
+1.19%
169.37
+0.53%
168.48
Ordinary Shares Number
172.88
+1.07%
171.04
+2.40%
167.03
+0.53%
166.15
Treasury Shares Number
0.33
+0.00%
0.33
-85.71%
2.33
+0.00%
2.33
Additional Paid In Capital
3,172.82
+0.12%
3,169.11
+6.45%
2,977.17
+5.66%
2,817.79
Retained Earnings
-3,883.99
-1.70%
-3,819.25
-11.46%
-3,426.56
-13.85%
-3,009.68
Gains Losses Not Affecting Retained Earnings
74.36
+2.54%
72.51
-4.06%
75.59
+27.31%
59.37
Treasury Stock
5.89
+0.00%
5.89
-85.59%
40.86
+0.00%
40.86
Minority Interest
1,023.41
+19.06%
859.55
-19.13%
1,062.83
+3.99%
1,022.02
Other Equity Adjustments
74.36
+2.54%
72.51
-4.06%
75.59
+27.31%
59.37
Total Equity Gross Minority Interest
380.76
+37.91%
276.10
-57.41%
648.24
-23.62%
848.70
Total Capitalization
-642.64
-10.15%
-583.45
-40.73%
-414.60
-139.21%
-173.32
Working Capital
307.08
+63.11%
188.27
-63.14%
510.71
-23.97%
671.76
Invested Capital
-481.66
-96.30%
-245.38
-4.15%
-235.61
-372.89%
86.34
Total Debt
256.77
-42.07%
443.23
+28.77%
344.19
-29.90%
491.01
Capital Lease Obligations
95.79
-8.91%
105.15
-36.35%
165.20
-28.59%
231.35
Net Tangible Assets
-644.08
-9.97%
-585.71
-40.17%
-417.87
-134.45%
-178.23
Tangible Book Value
-644.08
-9.97%
-585.71
-40.17%
-417.87
-134.45%
-178.23
Line Of Credit
160.98
-52.38%
338.07
+88.88%
178.99
-31.07%
259.66
Notes Receivable
78.83
+1.58%
77.60
+79.08%
43.33
-52.24%
90.73
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
263.02
+158.81%
-447.24
-1831.77%
-23.15
+96.64%
-688.84
Cash Flow From Continuing Operating Activities
263.02
+158.81%
-447.24
-1831.77%
-23.15
+96.64%
-688.84
Net Income From Continuing Operations
-20.78
+94.12%
-353.43
+6.02%
-376.07
+39.44%
-621.02
Depreciation Amortization Depletion
16.97
-22.10%
21.78
-46.64%
40.82
+49.95%
27.22
Depreciation
16.15
-22.23%
20.77
-46.86%
39.08
Amortization Cash Flow
0.81
-19.39%
1.01
-41.83%
1.74
Depreciation And Amortization
16.97
-22.10%
21.78
-46.64%
40.82
+49.95%
27.22
Amortization Of Intangibles
0.81
-19.39%
1.01
-41.83%
1.74
Other Non Cash Items
48.50
-22.54%
62.61
-9.68%
69.32
-22.79%
89.78
Stock Based Compensation
20.15
-91.11%
226.69
+39.87%
162.07
+11.32%
145.59
Provisionand Write Offof Assets
0.52
-73.38%
1.95
-27.62%
2.69
+101.19%
1.34
Asset Impairment Charge
3.89
-80.48%
19.91
-30.14%
28.50
-38.02%
45.98
Operating Gains Losses
1.11
+145.85%
-2.42
-147.97%
5.05
+164.32%
-7.85
Gain Loss On Investment Securities
0.17
+104.22%
-4.03
+4.49%
-4.21
+45.98%
-7.80
Net Foreign Currency Exchange Gain Loss
0.91
+49.18%
0.61
-92.25%
7.88
0.00
Gain Loss On Sale Of PPE
0.03
-96.88%
0.99
-28.63%
1.39
+2773.08%
-0.05
Change In Working Capital
192.66
+145.40%
-424.33
-1054.32%
44.46
+112.02%
-369.87
Change In Receivables
121.97
+244.92%
-84.16
-112.67%
-39.58
+87.65%
-320.55
Changes In Account Receivables
123.20
+346.91%
-49.90
+42.63%
-86.98
+64.12%
-242.40
Change In Inventory
28.11
-52.84%
59.59
+114.67%
-406.29
-1.43%
-400.55
Change In Prepaid Assets
-26.21
-145.86%
57.16
+244.75%
-39.49
-157.00%
69.28
Change In Payables And Accrued Expense
100.53
+124.72%
-406.71
-168.34%
595.14
+50.70%
394.92
Change In Accrued Expense
-32.20
+86.00%
-229.97
-229.46%
177.64
+46.91%
120.92
Change In Payable
132.73
+175.10%
-176.74
-142.33%
417.50
+52.37%
274.00
Change In Account Payable
132.73
+175.10%
-176.74
-142.33%
417.50
+52.37%
274.00
Change In Other Working Capital
3.71
-29.17%
5.25
+441.25%
-1.54
+30.10%
-2.20
Change In Other Current Assets
-1.37
-119.49%
7.04
+304.95%
1.74
+110.21%
-17.02
Change In Other Current Liabilities
-34.08
+45.47%
-62.50
+4.62%
-65.52
+30.11%
-93.75
Investing Cash Flow
37.38
-75.37%
151.74
+421.67%
-47.17
-178.44%
60.14
Cash Flow From Continuing Investing Activities
37.38
-75.37%
151.74
+421.67%
-47.17
-178.44%
60.14
Net PPE Purchase And Sale
-14.74
-80.34%
-8.17
+73.10%
-30.39
+51.20%
-62.28
Purchase Of PPE
-15.20
-54.74%
-9.82
+68.89%
-31.57
+49.56%
-62.59
Sale Of PPE
0.46
-72.21%
1.65
+39.07%
1.19
+275.00%
0.32
Capital Expenditure
-15.20
-54.70%
-9.82
+68.99%
-31.69
+49.45%
-62.69
Net Investment Purchase And Sale
52.12
-67.41%
159.92
+1266.28%
-13.71
-111.19%
122.51
Purchase Of Investment
-460.00
+49.69%
-914.33
+27.94%
-1,268.92
+30.86%
-1,835.43
Sale Of Investment
512.12
-52.33%
1,074.25
-14.42%
1,255.21
-35.89%
1,957.94
Net Business Purchase And Sale
0.00
0.00
+100.00%
-2.96
0.00
Purchase Of Business
0.00
0.00
+100.00%
-2.96
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.00
+97.37%
-0.11
-14.00%
-0.10
Purchase Of Intangibles
0.00
+100.00%
-0.00
+97.37%
-0.11
-14.00%
-0.10
Financing Cash Flow
-406.24
-297.22%
205.98
+806.00%
22.73
-69.42%
74.34
Cash Flow From Continuing Financing Activities
-406.24
-297.22%
205.98
+806.00%
22.73
-69.42%
74.34
Net Issuance Payments Of Debt
-177.09
-204.48%
169.51
+310.13%
-80.67
-365.29%
30.41
Issuance Of Debt
438.86
-52.28%
919.63
+16.68%
788.15
+93.73%
406.84
Repayment Of Debt
-615.96
+17.89%
-750.13
+13.66%
-868.82
-130.81%
-376.43
Long Term Debt Issuance
41.94
Net Long Term Debt Issuance
41.94
Short Term Debt Issuance
438.86
-52.28%
919.63
+16.68%
788.15
+93.73%
406.84
Short Term Debt Payments
-615.96
+17.89%
-750.13
+13.66%
-868.82
-130.81%
-376.43
Net Short Term Debt Issuance
-177.09
-204.48%
169.51
+310.13%
-80.67
-365.29%
30.41
Net Common Stock Issuance
0.01
-93.72%
0.22
-18.61%
0.27
+109.23%
-2.97
Common Stock Payments
0.00
0.00
+100.00%
-5.89
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-5.89
Net Other Financing Charges
-229.16
-732.21%
36.25
-64.85%
103.13
+119.89%
46.90
Changes In Cash
-105.84
-18.23%
-89.52
-88.11%
-47.59
+91.42%
-554.36
Effect Of Exchange Rate Changes
0.63
+116.88%
-3.72
-200.30%
3.71
+205.91%
-3.50
Beginning Cash Position
623.55
-13.01%
716.79
-5.77%
760.67
-42.31%
1,318.53
End Cash Position
518.33
-16.87%
623.55
-13.01%
716.79
-5.77%
760.67
Free Cash Flow
247.82
+154.22%
-457.07
-733.46%
-54.84
+92.70%
-751.53
Interest Paid Supplemental Data
6.16
-40.93%
10.42
+9.15%
9.55
+69.76%
5.62
Income Tax Paid Supplemental Data
0.10
-61.75%
0.25
0.00
0.00
Common Stock Issuance
0.01
-93.72%
0.22
-18.61%
0.27
-90.61%
2.92
Earnings Losses From Equity Investments
664.83
Issuance Of Capital Stock
0.01
-93.72%
0.22
-18.61%
0.27
-90.61%
2.92
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category